Technology, Science, & Me!: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology, Science, & Me!.

Press releases published on July 24, 2026

Jul. 24, 2026

Third Business Unit of Tier-1 Israeli-Based Global Defense Company Places DefendAir Net Pod Order with ParaZero

Indeterminate GlobeNewswire

Jul. 24, 2026

GE Aerospace Wraps Historic Farnborough Airshow

Indeterminate GlobeNewswire

Jul. 24, 2026

NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

Indeterminate GlobeNewswire

Jul. 24, 2026

ArcelorMittal announces the publication of its second quarter 2026 sell-side analyst consensus figures

Indeterminate GlobeNewswire

Jul. 24, 2026

D-BOX Technologies, Inc. to Launch Motion Seating in Multiple Auditoriums at Marcus Theatres Locations in Oakdale, Minn. and Orland Park, Ill.

Indeterminate GlobeNewswire

Jul. 24, 2026

Technologies D-BOX Inc. lancera des sièges à mouvement dans plusieurs salles des cinémas Marcus Theatres à Oakdale (Minnesota) et Orland Park (Illinois)

Indeterminate GlobeNewswire

Jul. 24, 2026

넥스데이타, KCCV 2026 참가… 차세대 AI 데이터 솔루션 공개

Indeterminate EIN Presswire

Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

Indeterminate GlobeNewswire

Jul. 24, 2026

Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire

Jul. 24, 2026

Silicon Motion Confirms Quarterly Dividend

Indeterminate GlobeNewswire

Jul. 24, 2026

BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe

Indeterminate GlobeNewswire

Jul. 24, 2026

Dyadic Announces Continued Listing on the Nasdaq Capital Market

Indeterminate GlobeNewswire

Jul. 24, 2026

Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union

Indeterminate GlobeNewswire

Jul. 24, 2026

SPIRIT BLOCKCHAIN CAPITAL APPOINTS SUHA ASKARY AS CHIEF EXECUTIVE OFFICER

Indeterminate GlobeNewswire

Jul. 24, 2026

Persica Pharmaceuticals presents new analyses of microbiology assay sensitivity and intradiscal antibiotic exposure response in chronic Low Back Pain at ASPN 2026 Annual Conference

Indeterminate GlobeNewswire

Jul. 24, 2026

Verizon Delivers Record 2Q26 Results as Strategic Transformation Ignites Accelerated Growth

Indeterminate GlobeNewswire

Jul. 24, 2026

Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models

Indeterminate GlobeNewswire

Jul. 24, 2026

ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

Indeterminate GlobeNewswire

Jul. 24, 2026

Einride to Host First Half 2026 Earnings Conference Call on August 18, 2026

Indeterminate GlobeNewswire

Jul. 24, 2026

Nova Minerals Highlights Strategic Alignment with U.S. Defense Supply Chain Priorities Under White House Executive Order

Indeterminate GlobeNewswire